U0126-EtOH

CAS号

1173097-76-1

分子式

C18H16N6S2·C2H6O

主要靶点

MEK|Autophagy|Mitophagy|Influenza Virus

仅限科研使用

Cat No : CM05075

Print datasheet

Synonyms

Influenza Virus|InfluenzaVirus|inhibit|Autophagy|competitive|virus|U-0126|U0126 Ethanol|U0126 EtOH|U0126EtOH|U-0126-EtOH|U0126-EtOH|U0126|U 0126|MAP2K|MAPKK|Mitophagy|Mitogen-activated protein kinase kinase|Mitochondrial Autophagy|MEK|MEK1|MEK2|Inhibitor|non-ATP|progeny



产品信息

CAS号 1173097-76-1
分子式 C18H16N6S2·C2H6O
主要靶点 MEK|Autophagy|Mitophagy|Influenza Virus
主要通路 自噬|MAPK 信号通路|微生物学|自噬
分子量 426.6
纯度 99.82%, 此纯度可做参考,具体纯度与批次有关系,可咨询客服
储存条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
别名 Influenza Virus|InfluenzaVirus|inhibit|Autophagy|competitive|virus|U-0126|U0126 Ethanol|U0126 EtOH|U0126EtOH|U-0126-EtOH|U0126-EtOH|U0126|U 0126|MAP2K|MAPKK|Mitophagy|Mitogen-activated protein kinase kinase|Mitochondrial Autophagy|MEK|MEK1|MEK2|Inhibitor|non-ATP|progeny

靶点活性

MEK1:70 nM (cell free)|MEK2:60 nM (cell free)

体内活性

将小鼠通过气雾剂途径处理U0126,导致了以下结果:(i) 抑制了肺部MEK激活 (ii) 相比未经处理的对照组,减少了后代IAV滴度 (iii) 保护了IAV感染的小鼠,对抗100倍致死性病毒挑战[4]。在所有U0126 (10.5 mg/kg) 实验中,移植和早期肿瘤生长显著减少。此外,在注射后第9天及以后,用U0126处理的肿瘤体积减少了60-70%。U0126处理的小鼠中Cdk1表达也大幅降低[5]。

体外活性

U0126通过非竞争性抑制具有双特异性的激酶MEK的活性,从而抵抗AP-1转录活性,其IC50分别对MEK 1为0.07 microM,对MEK 2为0.06 microM [1]。在用TPA/血清处理的成纤维细胞中,U0126可以降低c-Fos和c-Jun蛋白的上调50-80%。使用10 μM U0126处理不会影响SP-1、JunD及Fra-1等本质上表达的转录因子的蛋白水平[2]。在HEK293细胞中,U0126导致AMPK的磷酸化和激活,并增加了其下游靶标乙酰-CoA羧化酶的磷酸化,这一效应仅在表达上游激酶LKB1的细胞中发生[3]。

溶解度

DMSO:55 mg/mL (128.93 mM); Ethanol:< 1 mg/mL (insoluble or slightly soluble);

细胞实验

HEK293 cells were maintained in Dulbecco's modification of Eagle's medium (low glucose) plus 10% foetal bovine serum. HeLa cells stably expressing wild type or kinase-dead LKB1 have been described. AMPK activity was determined by immunoprecipitate kinase assays using anti-AMPK-a1 and -a2 antibodies. Antibodies recognising AMPK phosphorylated on Thr-172 (anti-pT172), AMPK-α1 and -α2 and acetyl-CoA carboxylase-1 (ACC1) phosphorylated on Ser-80 [16] were described previously. Quantification of ratios of signals from phosphorylated and total protein using these antibodies was performed by dual labelling using the LI-COR Odyssey IR imager as described. Contents of ATP and ADP were determined for cells in 6 cm culture dishes by quickly pouring off the medium, adding 350 μl of ice-cold 5% perchloric acid, scraping the cells off with a plastic scraper, and centrifuging (14 000 · g; 3 min, 4 °C) to remove insoluble material. The perchloric acid was then extracted from the supernatant and nucleotides analysed by capillary electrophoresis of perchloric acid extracts as described previously. All incubations of cells were performed in triplicate and results are expressed as means ± S.E.M [3].

动物实验

Prior to injection, FI cells were labeled with a stable fluorescent dye molecule, DiA at 10 μg/ml for 5 h at 37 1C. After washing to remove free DiA, cells were trypsinized for inoculation (U0126 experiments) or transfection (RNAi experiments). Biliary epithelial cells were injected subcutaneously, at the indicated times, into the tibia of nude mice. In the chemical experiments, 3h after inoculation, mice were treated with U0126 (10.5 mg/kg) daily by intraperitoneal injection. The length and width of each tumor were measured every day by using a caliper. The following formula was used to calculate tumor volumes ? width2 length/2. Mice were killed at the end of experiment. Tumors were immediately frozen in liquid nitrogen [5].

参考文献

1.Duncia JV, et al. MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett. 1998, 8(20), 2839-2844.
2.Zhou B, Yan J, Guo L, et al. Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma[J]. Theranostics. 2020, 10(14): 6530.
3.Favata MF, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 1998 Jul 17;273(29):18623-32.
4.Dokladda K, et al. PD98059 and U0126 activate AMP-activated protein kinase by increasing the cellular AMP:ATP ratio and not via inhibition of the MAP kinase pathway. FEBS Lett. 2005 Jan 3;579(1):236-40.
5.Droebner K, et al. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antiviral Res. 2011 Nov;92(2):195-203.
6.Bessard A, et al. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo. Oncogene. 2008 Sep 11;27(40):5315-25.
7.Ahnstedt H, et al. U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats. J Cereb Blood Flow Metab. 2015 Mar;35(3):454-60.
8.Zeng H, Pathak J L, Shi Y, et al. Indirect selective laser sintering-printed microporous biphasic calcium phosphate scaffold promotes endogenous bone regeneration via activation of ERK1/2 signaling[J]. Biofabrication. 2020, 12(2): 025032.
9.Shao S, Xia H, Hu M, et al. Isotalatizidine, a C 19-diterpenoid alkaloid, attenuates chronic neuropathic pain through stimulating ERK/CREB signaling pathway-mediated microglial dynorphin A expression[J]. Journal of Neuroinflammation. 2020, 17(1): 1-11.
10.Zeng H, Pathak J L, Shi Y, et al. Indirect selective laser sintering printed microporous biphasic calcium phosphate scaffold promotes endogenous bone regeneration via activation of ERK1/2 signaling[J]. Biofabrication. 2020.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
=
×
×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
×
=
×
C1   V1   C2   V2